Concepedia

Melissa P. Lokugamage

MP

Statistics

Publications

21

Citations

2.5K

H-Index

18

Active since

2016

Affiliations

Georgia Institute of Technology(Current)

The Wallace H. Coulter Department of Biomedical Engineering

Emory University

Guided Therapeutics (United States)

Melissa P. Lokugamage is an author at Georgia Institute of Technology specializing in lipid nanoparticles, nanomedicine, and molecular biology.

ORCID

Publications per year

2016–2025

21

Publications

21

Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs

Melissa P. Lokugamage, Daryll Vanover, Jared Beyersdorf et al. · Nature Biomedical Engineering · 2021 · 466 citations · Full text

, , +14

High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing

Cory D. Sago, Melissa P. Lokugamage, Kalina Paunovska et al. · Proceedings of the National Academy of Sciences · 2018 · 300 citations · Full text

, , +17

Nanoparticles Containing Oxidized Cholesterol Deliver mRNA to the Liver Microenvironment at Clinically Relevant Doses

Kalina Paunovska, Alejandro J. Da Silva Sanchez, Cory D. Sago et al. · Advanced Materials · 2019 · 194 citations

, , +17

Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo

Huanzhen Ni, Marine Z. C. Hatit, Kun Zhao et al. · Nature Communications · 2022 · 179 citations · Full text

, , +17

Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting Ligands

Melissa P. Lokugamage, Cory D. Sago, Zubao Gan et al. · Advanced Materials · 2019 · 158 citations · Full text

, , +16

1–5 of 21